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May 30
th
 (Friday)  
8h15 – Opening Session  
8h40 – Symposium 1 – Dosimetry and Radiation Protection 
10h20 – Coffee Break    |    Poster Presentation 
10h50 – Symposium 2 – Radiopharmaceutical Therapy 
11h50 – Oral Communications 
12h40 – Lunch 
14h30 – Symposium 3 – Nuclear Medicine – From bench to bedside 
16h00 – Coffee Break    |    Poster Presentation 
16h30 – Symposium 4 – Quantification and Corrections in Nuclear Medicine 
18h00 – Cultural Moment 
20h00 – Conference Dinner 
 
May 31
st
 (Saturday) 
8h00 – Oral Communications 
9h00 – Symposium 5 – Nuclear Medicine Education and Competencies 
10h00 – Coffee Break    |    Poster Presentation 
10h30 – Symposium 6 – International Round Table 
11h30 – Symposium 7 – Erasmus+ Challenges and Possibilities for Networks 
12h30 – Closing Ceremony / Conference Highlights / Awards Ceremony 
 
 15h00-18h00 – Workshop 
 Tomographic reconstruction – a fundamental part in the future of medical imaging. 
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Abstracts – Oral Communications 
 
OC – 01 
11h50-12h40, Friday, May 30, 2014 
 
The impact of wearing lead aprons on the radiation exposure of staff performing nuclear 
medicine procedures using Tc-99m 
Pestean Claudiu1; Larg Maria Iulia1; Sabo Alexandrina1; Crisan Monica1 
 
1 Oncology Institute "Prof. Dr. I. Chiricuta" Cluj-Napoca / Nuclear Medicine Department 
 
Aim: We assess the impact of lead aprons on the annual effective dose of staff during elution of a Tc-
99m generator, preparation and administration of radiopharmaceuticals. We evaluate the impact in 
relation with the annual staff exposure. We discuss the impact of these protective measures in relation 
with the optimization principle of radiation protection stated by the European regulations. 
Methodology: The study was conducted over two weeks, a Tc-99m generator life. A physicist and a 
technologist were involved, performing preparation and administration of radiopharmaceutical. They 
had worn 0.5mm lead aprons. They have been equipped with two DMC2000S dosimeters, one under 
and one over the apron and they recorded the exposure. A total activity of 44GBq has been 
manipulated. The physicist spent 1h and 50min over the entire study for elution and preparation. The 
technologist spent 4h and 9min for administration. All the procedures have been performed using 
tungsten shields for syringes and vials. 
Results: Physicist’s dosimeter situated under the apron recorded an effective dose 0.020μSv and the 
dosimeter over the apron recorded 0.023μSv, which means a reduction of 0.003μSv (13.04%). 
Technologist’s dosimeter worn under the apron recorded an effective dose of 0.018μSv and the 
dosimeter over the apron measured 0.022μSv. The reduction was 0.004μSv (18.18%). 
Discussions and conclusions: Considering the work conditions described above as usual work conditions 
over a year and taking into account the exposure in our department, we estimated that the dose 
reduction wearing 0.5mm lead aprons would have a maximum value of 0.096μSv, which represents 
0.0064% from the average annual exposure of the staff in our department, which is 1.5mSv. With these 
values and considering that the optimization of the radiation exposure must be applied taking into 
account all the societal and economical factors we consider that the reduction is minimal and it is 
reasonable to not wear lead aprons. 
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OC– 02 
11h50-12h40, Friday, May 30, 2014 
 
Synthesis of Porphyrin Derivatives and Labeling with 186Rehnium 
Tjahjono, Daryono Hadi1; Zein, Faujan M1; Surantaatmadja, Slamet Ibrahim1; Mutalib, Abdul2 
 
1School of Pharmacy, Bandung Institute of Technology 
2Center for Development of Radionuclide and Radiopharmaceutical, National Nuclear Energy Agency 
 
Introduction: Porphyrin are versatile compounds. It bind to DNA of cancer cell selectively with higher 
binding constant compare to that of normal cell. Although porphyrin can not be coordinated by metal 
with large radii, its meso-substituens can be modify easily. By introducing two carboxylic groups at 
phenyl of meso-position, it will provide ligand for complexation with gamma and beta emitting 
radionuclides such as 
99m
Technectium (
99m
Tc) and 
186
Rhenium (
186
Re). Thus, labelled-porphyin can be 
used for cancer diagnosis and therapy. In the present research, novel porphyrins bearing two carboxylic 
groups at the meso-positions, meso-5,15-di[3,4-bis(carboxy-methylenoxy)phenyl] porphyrin (DCP) and 
meso-5,15-di[3,4-bis(carboxymethylenoxy)-phenyl],10,20-diphenyl porphyrin (DCDPP) have been 
synthesized. Labelling of DCDPP with 
186
Re was also studied. 
Methodology: Porphyrin was synthesized using starting material of dipyrromethane and related 
aldehyde. Labelling of porphyrin with beta emitting radionuclide of 
186
Re at the carboxylic of ¬meso-
substituent used indirect procedure. Radiochemical purification was performed using instant thin layer 
chromatography. 
Results and discussion: The results showed that reduction using NaBH4 was comparable to SnCl2 in low 
concentration. The trans-chelating reaction was carried out to stabilize the unstable 
186
Re(v), due to 
186
Re(v) was easily back-oxidized to 
186
Re(vii). Due to the problem, first the 
186
Re(v) was complexed using 
Na-gluconate to form a stable Re-gluconate chelate. The trans-chelation reaction with porphyrin can be 
then carried out because porphyrin has higher affinity to the 
186
Re(v) than that of gluconate. The 
optimum condition of labeling using trans-chelation reaction applied 2 mg of SnCl2 as the reductor, pH 
of 4-5, and 60 min incubation at rt. 
Conclusion: Two novel porphyrins bearing two carboxylic groups at the meso-positions (DCP and DCDPP) 
have been synthesized. Labelling efficiency of DCDPP with 
186
Re was 92%. 
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OC – 03 
11h50-12h40, Friday, May 30, 2014 
 
Phytochemicals as Radio-sensitizing agents in Nuclear Medicine therapy 
Nuno Lemos1 
1Nuclear Medicine Technologist 
 
90Y-Zevalin and 131I-Bexxar are both radiopharmaceuticals of choice in the treatment of Non-
Hodgkin lymphoma. However treatment with these radiopharmaceuticals is not without side 
effects. One of the ways to try to reduce these effects is by reducing the dose administered to 
the patient. However decreasing the dose administered brings a reduction of its therapeutic 
effectiveness. Maintain or increase the clinical benefits of radioimmunotherapy and lower 
radiation doses is only possible if the cell finds itself more vulnerable to the effects of 
radiotoxic radiopharmaceuticals. Radiosensitizers agents are beginning to be studied using the 
traditional pharmacopoeias as a starting point. Phytochemicals have proven themselves 
promising as radioprotective, radiorecovery and/or radiosensitizers agents. Curcumin is a 
phytochemical present in curries, with strong radiosensitizer effect and proven 
antitumorigenic activity. However bioavailability has been weak so it´s necessary to think of 
different strategies to ensure maximum radiosensibilization. A strategy that is beginning to be 
explored is the encapsulation of curcumin into nanoparticles. This project aims to stimulate 
interest in this area of therapeutic nuclear medicine. The project consists of preparing 
nanoparticles containing curcumin and functionalized with antibodies having affinity for 
antigens present on cells of non-Hodgkin lymphoma and in the evaluation of the influence of 
curcumin nanoparticles to the cytotoxic effects of radiopharmaceuticals with consequent 
studies of associated cellular mechanisms. 
 
 
  
 5 I International Conference of Nuclear Medicine Technologies 
 
OC – 04 
11h50-12h40, Friday, May 30, 2014 
Nuclear Pharmacy Integrated Course For Students In Pharmacy, Medicine, Medical Physics 
and Nuclear Chemistry (NuPhICoS) 
 
E. Milieva1, M. Murdjeva1, A. Soylu2, A. Yordanov2, M. Yaneva1, I. Kostadinova3, P. Trindev3, B. Todorov4, M. Karaivanova1, D. 
Adliene5, E. Soursa6, Cs. Pesznyak7, V. Zemite8, D. Legrady7, M. Anagnostakis9, F. Lucena6, D. Bosnar10, G. Adlys5, T. Dimitrova11, V. 
Stanchev1; S. Ivanova3; J. Krasteva3, N. Veleva1; P. Michailova1; T. Petrov3; M. Garcheva3; U. Tansel12, A. Filazi12 
1 MU-Plovdiv, BG; 2 Eczacıbaşı Monrol, TR; 3 MU-Sofia, BG; 4 SU-Sofia, BG; 5 KTU-Kaunas, LT; 6 ESTeSL-Lisbon, PT; 7 BME-
Budapest, HU; 8 RTU-Riga, LV; 9 NTU-Athens, Greece; 10 UZ-Zagreb, HG; 11 PU-Plovdiv, BG; 12 AU-Ankara, TR 
 
The projected annual sales of radiopharmaceuticals in the U.S.A. and Europe are expected to 
reach 5.4 bln $. This is in conjunction with the development and the introduction of new 
diagnostic and therapeutic methods in the nuclear medicine (NM) field. The goal of this project 
is to develop an educational programme in nuclear pharmacy for integrated interactive 
education of students from different majors - Nuclear Pharmacy Integrated Course for 
Students in Pharmacy, Medicine, Medical Physics and Nuclear Chemistry - NuPhICoS (Erasmus 
Projects 2012-1-BG1-ERA 10–07058; 2013-1-BG1-ERA10-00320). The major activities 
correspond to the requirements for innovation and multidiscipline studies: lectures, laboratory 
exercises, learning projects, presented/defended during topic-oriented seminars. Targeted 
group: 11 Higher Education Institutions (HEI) from 8 countries (Bulgaria, Greece, Lithuania, 
Portugal, Latvia, Hungary, Croatia and Turkey). The students (mostly undergraduate) are 
majors in 5 disciplines (pharmacy, medicine, medical physics/physics, 
radiochemistry/chemistry, and NM technologies) are directly involved in the method 
development, production and applications of radionuclides and radiopharmaceuticals in NM. 
Closer collaboration within the HEI through the establishment of bilateral agreements 
between all programme partners for students and teachers mobility; adaptation/moderation 
of the current curriculums of the majors in the participating HEI; joint training of more than 80 
students; production of learning materials; development of more than 30 student projects. 
Work in progress: an optional course in Nuclear Pharmacy; common MSc in Nuclear Pharmacy 
between the IP partners. The development of NuPhiCoS under the European umbrella, with 
focus on the education of students from different majors has evidenced several results, both in 
the Institutional level and in the scientific and pedagogical level, with positive outcomes for 
the students and for the majors involved. 
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11h50-12h40, Friday, May 30, 2014 
Differences in the concentration of cholecystokinin and infusion duration: does the 
manipulation of these two parameters result in similar values of gallbladder ejection 
fraction? 
Marta S. Prates1; Marta D. Azêdo4; Russell Arey3, 4; James Milton3, 4; Rebecca Modiste4; Melinda Walker3,4; Tânia F. Vaz2 
1 Nuclear Medicine Technologist 
2 Lisbon School of Health Technology – Lisbon Polytechnic Institute 
3 North Shore Medical Center  – Salem Hospital, Nuclear Medicine Department 
4 Salem State University – Nuclear Medicine Technology Program 
 
Introduction: The Hepatobiliary Iminodiacetic Acid scan (HIDA scan) is widely used in the 
United States of America due to the incidence of hepatobiliary disease. Even though guidelines 
have been published in order to standardize practice, hospitals tend to adapt these to their 
own daily routine. Therefore, our purpose was to assess the influence of two protocols 
(0.02µg/kg or 0.04µg/kg of cholecystokinin (CCK) infused during 45 or 30 minutes, 
respectively) in the values of gallbladder ejection fraction (GBEF), being the cut-off value of 
35%. 
Methodology: This was a retrospective study where 48 symptomatic patients, referred for 
HIDA scan due to clinical reasons, were randomly chosen and divided in two groups of 24 
patients each, according to the performed protocol (Group I (GI): 0.02µg/kg of CCK infused 
during 45 minutes; Group II (GII): 0.04µg/kg of CCK infused during 30 minutes). Statistical 
analysis was applied to assess the characteristics of the groups and also to evaluate if there 
were statistically significant differences in the GBEF. 
Results: Among other results, GI showed generally higher GBEF with 71±24.9% (mean±SD) and 
only 8.3% (2 patients) of the patients had GBEF≤35%, compared with GII (56±30.2% and 8 
patients (33.3%), respectively). Despite this, the results demonstrated no statistically 
significant differences for the GBEF. 
Conclusions: It’s possible to vary the CCK concentration and infusion duration, without 
significantly changes of the GBEF. However the topic should be further investigated due to 
some limitations of this study. 
 
 7 I International Conference of Nuclear Medicine Technologies 
 
OC – 06 
8h00-9h00, Saturday, May 31, 2014 
Performing PET/CT studies: do they create Anxiety? 
Carla Abreu1; Filipa Lucena2; Ana grilo2 
1 PET Imaging Centre, St Thomas' Hospital 
2 Lisbon School of Health Technology, Lisbon Polytechnic Institute 
 
Introduction: Anxiety is a common problem in primary care and specialty medical settings. 
Treating an anxious patient takes more time and adds stress to staff. Unrecognised anxiety 
may lead to exam repetition, image artifacts and hinder the scan performance. Reducing 
patient anxiety at the onset is probably the most useful means of minimizing artifactual FDG 
uptake, both fat brown and skeletal muscle uptake, as well patient movement and 
claustrophobia. The aim of the study was to examine the effects of information giving on the 
anxiety levels of patients who are to undergo a PET/CT and whether the patient experience is 
enhanced with the creation of a guideline. 
Methodology: Two hundred and thirty two patients were given two questionnaires before and 
after the procedure to determine their prior knowledge, concerns, expectations and 
experiences about the study. Verbal information was given by one of the technologists after 
the completion of the first questionnaire. 
Results: Our results show that the main causes of anxiety in patients who are having a PET/CT 
is the fear of the procedure itself, and fear of the results. The patients who suffered from 
greater anxiety were those who were scanned during the initial stage of a disease. No 
significant differences were found between the anxiety levels pre procedural and post 
procedural. Findings with regard to satisfaction show us that the amount of information given 
before the procedure does not change the anxiety levels and therefore, does not influence 
patient satisfaction. 
Conclusions: The performance of a PET/CT scan is an important and statistically generator of 
anxiety. PET/CT patients are often poorly informed and present with a range of anxieties that 
may ultimately affect examination quality. The creation of a guideline may reduce the stress of 
not knowing what will happen, the anxiety created and may increase their satisfaction in the 
experience of having a PET/CT scan. 
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8h00-9h00, Saturday, May 31, 2014 
18F-FDG measurement in primary lung cancer: SUV normalization to different distribution 
volumes 
Estevão Badgi1; Beatriz Santos2;Filipa Lucena3; Isabel Conde4 
1 Hammersmith Medicines Research 
2 Nuclear Medicine Technologist 
3 Lisbon School of Health Technology, Lisbon Polytechnic Institute 
4 Serviço de Medicina Nuclear, Quadrantes – Clínica Médica e de Diagnóstico, Algés, Portugal 
 
Introduction: Standard Uptake Value (SUV) is a measurement of the uptake in a tumour 
normalized on the basis of a distribution volume and is used to quantify 18F-Fluorodeoxiglucose 
(FDG) uptake in tumors, such as primary lung tumor. Several sources of error can affect its 
accuracy. Normalization can be based on body weight, body surface area (BSA) and lean body 
mass (LBM). The aim of this study is to compare the influence of 3 normalization volumes in 
the calculation of SUV: body weight (SUVW), BSA (SUVBSA) and LBM (SUVLBM), with and 
without glucose correction, in patients with known primary lung tumor. The correlation 
between SUV and weight, height, blood glucose level, injected activity and time between 
injection and image acquisition is evaluated. 
Methods: Sample included 30 subjects (8 female and 22 male) with primary lung tumor, with 
clinical indication for 18F-FDG Positron Emission Tomography (PET). Images were acquired on a 
Siemens Biography according to the department’s protocol. Maximum pixel SUVW was 
obtained for abnormal uptake focus through semiautomatic VOI with Quantification 3D 
isocontour (threshold 2.5). The concentration of radioactivity (kBq/ml) was obtained from 
SUVW, SUVBSA, SUVLBM and the glucose corrected SUV were mathematically obtained. 
Results: Statistically significant differences between SUVW, SUVBSA and SUVLBM and between 
SUVWgluc, SUVBSAgluc and SUVLBMgluc were observed (p=0.000<0.05). The blood glucose 
level showed significant positive correlations with SUVW (r=0.371; p=0.043) and SUVLBM 
(r=0.389; p=0.034). SUVBSA showed independence of variations with the blood glucose level. 
Conclusion: The measurement of a radiopharmaceutical tumor uptake normalized on the basis 
of different distribution volumes is still variable. Further investigation on this subject is 
recommended. 
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8h00-9h00, Saturday, May 31, 2014 
 
Myocardial partial volume effect: the importance of intra-ventricular structures 
Mauro Sousa1 
 
1Institute of Nuclear Medicine, University College of London Hospitals/ Institute of Biophysics and Biomedical Engineering (IBEB) 
 
Introduction: In emission tomography, the system’s limited spatial resolution leads to three-
dimensional image blurring, a phenomenon called partial volume effect (PVE). The limited 
resolution gives rise to activity spillover between regions in the imaging object, producing 
significant alterations in the activity distribution, especially for small structures. In this sense, 
precise quantification based on image activity values depends on a rigorously implemented 
partial volume correction (PVC) plan. In nuclear medicine images some PVC methodologies 
make use of corresponding anatomical images in order to provide additional information 
which assist in the correction procedure. This approach is popular for cardiac emission images. 
However, in previous PVC literature, cardiac intra-ventricular structures (IVS), namely papillary 
muscles and trabeculae carneae, have been largely ignored, while they may potentially have a 
significant influence in terms of activity spillover.  
Methods: A simulation study to investigate the effect of IVS was performed in Matlab. A 
diastolic left ventricle (LV) model with IVS was constructed, according to the 17 segment 
clinical model. The model was blurred and the amount of activity spilled from the IVS to the 
wall was quantified in a total and segment-wise way.  The parameters of IVS diameter, 
distance to the LV wall and LV wall thickness were varied. The blood pool (BP) influence was 
also determined. 
Results: The studies showed essentially that for the typical range of parameter values, IVS PVE 
influence was determined to be comparable with that of the BP. 
Conclusion: Since the BP is regarded as significant in PVC literature, the study showed evidence 
that the influence of IVS in terms of myocardial PVE is therefore relevant as well. Despite the 
assumptions used in the simulation, this study justifies a similar implementation with clinical 
functional and corresponding anatomical images. 
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Cardiac Rb-82 PET/CT: Optimization of image acquisition and reconstruction parameters 
P. Chilra1,3,4, S. Gnesin2-3, G. Allenbach3, J. O. Prior3, L. Vieira4-5, and J. Jorge1 
1Haute École de Santé Vaud - Filière TRM, University of Applied Sciences Western Switzerland 
2Institute of Radiation Physics, Lausanne University Hospital  
3Nuclear Medicine Department, Lausanne University Hospital 
4Lisbon School of Health Technology, Lisbon Polytechnic Institute  
5Instituto de Biofísica e Engenharia Biomédica, Faculdade de Ciências da Universidade de Lisboa 
 
Purpose: To investigate the influence of Time-of-Flight (TOF)+Point Spread Function (PSF) 
corrections, and reconstruction parameters (iterations×subsets numbers, as well as filters 
FWHM) in ordered-subsets expectation maximization (OSEM) algorithms in 82Rb cardiac 
PET/CT. 
Materials and Methods: Rest and adenosine-induced stress listmode data from 10 patients 
with myocardial blood flow (MBF) abnormalities and 10 patients without were reconstructed 
with different parameters (OSEM; OSEM+TOF; OSEM+TOF+PSF). In total, 320 reconstructions 
were performed with 4-, 6- and 8-mm FWHM Gaussian filters and different iterations×subsets 
numbers (2×24; 2×16; 3×16; 4×16). Segmental MBF were computed using FlowQuant© (OHI, 
Ottawa, Canada). We analysed differences to the original clinical reconstruction protocol using 
Lin’s coefficient of concordance (ρc, a measure of precision and accuracy) and Bland-Altman 
(BA) plots. 
Results: Mean differences in MBF were small with excellent concordance as compared to the 
clinical protocol (all ρc>0.94), except for when TOF was removed (rest: ρc=0.79, stress: ρc=0.86, 
P<0.05). Changes in iterations×subsets or filters did not influence (P>0.05). 
Conclusion: Changes in reconstruction iterations×subsets numbers or filters only remotely 
influenced MBF measurements. The only significant, but small differences were observed in 
rest+stress MBF for reconstructions without TOF. Further work is needed to optimize the 
protocol for cardiac PET/CT with 82Rb. 
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10h20-10h50, Friday, May 30, 2014 
 
Clinical findings and protocol modification in the scintigraphy with 99mTc-Sestamibi for 
evaluation of the parathyroid glands 
Daniela Ribeiro1,2; Marco Pinheiro2; Elvira Fonseca2; Guilhermina Cantinho2 
1 Lisbon School of Health Technology, Lisbon Polytechnic Institute 
2Atomedical, Laboratory of Nuclear Medicine 
 
Introduction: This clinical case will demonstrate the clinical findings that can be observed in a 
Scintigraphy with 99mTc-Sestamibi for evaluation of the parathyroid glands and which can be 
correlated with the variable biodistribution of the radiopharmaceutical and with the 
pathophysiology of Hyperthyroidism. Due to the possibility of ectopic parathyroid tissue and to 
determine the origin of the Hyperthyroidism, a modification to the department’s protocol was 
performed. 
Methodology: Initially it was administered 740 MBq of 99mTc-Sestamibi, intravenously. Twenty 
minutes after the administration, an early static image was acquired, followed by the 
acquisition of a later static image, three hours after the administration. A whole body image 
was also acquired, reflecting a modification to the protocol, due to the clinical indication. A 
tomography study was performed in order to increase sensitivity. The exam ended with the 
acquisition of a static image, twenty minutes after the administration of 555 MBq of 99mTcO4
-. 
Results: The early and later static images, the whole body image and the tomography image 
reflected the 99mTc-Sestamibi’s biodistribution and the thyroid image reflected the 99mTcO4
- 
biodistribution. However, the first set of images demonstrated a diffuse and symmetrical 
uptake on both axillae which can be related to the 99mTc-Sestamibi’s uptake in the sweat 
glands. It was also visualized an uptake on the left humerus. 
Conclusion: There was a hyperfunction of the right inferior parathyroid, which is the result of 
the presence of a solitary adenoma. There was no evidence of ectopic tissue.  It is of 
importance to know the biodistribution of the radiopharmaceutical in order to distinguish the 
sweat glands’ uptake from extravasation or lymphatic metastasis, and also to be aware of the 
uptake mechanism and the pathophyisiology of the disease, to relate the uptake in regions of 
elevated metabolism and cellular proliferation dependent of energy. 
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PP – 02 
10h20-10h50, Friday, May 30, 2014 
 
A renal fusion case: the nuclear medicine approach 
Joana Santos1; Ana Graça2; Rafael Pinto2; vieira Marques2; Helena Pena2; Guilhermina Cantinho2 
1 Lisbon School of Health Technology, Lisbon Polytechnic Institute 
2 Instituto de Medicina Nuclear da Faculdade de Medicina da Universidade de Lisboa 
 
Introduction: Nowadays, nuclear medicine (NM) is very useful in paediatric evaluation, 
especially in the urinary system. This case shows a renogram in a child with 1 month that was 
admitted to the Instituto de Medicina Nuclear da Faculdade de Medicina da Universidade de 
Lisboa with suspicion of hydronephrosis, and pelvic left kidney with possible renal fusion. 
Methodology: The renogram was performed with a double injection of 99mTc-MAG3 because 
there was no progression of the radiopharmaceutical (RF) into bloodstream with the first 
injection. It was performed in anterior and posterior projections because of suspected pelvic 
kidney. Two dynamic evaluations (standard and diuretic renogram), a static image after 
voiding and the processing phase were performed according to the institutional protocols. Two 
regions of interest (kidney and bladder) were drawn in the dynamic evaluations and 
time/activity curves were obtained.bResults and Discussion: During the processing phase was 
observed that the patient change his position and the cardiac region was out of the field of 
view in the beginning of the study. So, the renographic curves and the quantitative values 
presented by the processing application were skewed. Results' distortion was also due 
extravasation of the RF at the site of administration. Visual analysis and time/activity curves of 
bladder and kidney showed an evident function of the pelvic renal mass. Diuretic renogram 
revealed the absence of mechanic obstruction. One week later, a renal scintigraphy with 99mTc-
DMSA was performed to clarify the presence of renal fusion. It included anterior, posterior and 
oblique posterior static images of the abdominopelvic area. We also acquired a tomographic 
study that confirmed the presence of renal fusion. Conclusion: This case shows the importance 
of the quality control during processing’s phase in NM, because without that approach the 
quantitative results wouldn’t be representative of the clinical condition of the child. 
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Multi-imaging modalities in refractory Idiopathic Thrombocytopenic Purpura (ITP): A case 
report 
Hassanzadeh Rad, Arman1; Fard-Esfahani, Armaghan1; Emami-Ardekani, Alireza1; Farsiabi, Fatemeh1; Beiki, Davood1; Eftekhari, 
Mohammad1 
1Research Institute for Nuclear Medicine, Tehran University of Medical Sciences 
 
Introduction: Idiopathic Thrombocytopenic Purpura (ITP) is due to autoantibodies against 
platelets causing thrombocytopenia. Splenectomy is the surgical procedure of choice for 
refractory ITP treatment, however; some patients continue to suffer from thrombocytopenia 
after surgery due to presence of accessory spleen. Scintigraphic imaging with 99mTc-labeled 
agents has important diagnostic role in this setting.  
Method: Our patient was a 31-year old woman, with multiple episodes of ecchymosis and 
thrombocytopenia due to ITP, refractory to corticosteroids, intravenous immunoglobulin 
therapy and splenectomy. On her last episode of thrombocytopenia, abdominal and pelvic 
ultrasound (US) and CT scan, 99mTc-phytate and 99mTc- denatured RBC (Tc-DRBC) scans were 
performed. 
Results: Abdominal US showed one hypoechoic lesion in the superior aspect of the left kidney. 
Abdominal CT scan revealed one soft tissue lesion posterior to the stomach. 99mTc-Phytate 
imaging showed no abnormality.  99mTc- DRBC scan (planar and SPECT images) revealed two 
discrete foci of abnormal uptake: one located posterior to the stomach and the other in the 
left paraspinal region superior to the left kidney (corresponding to the lesions reported in the 
CT scan and US respectively). 
Discussion: Treatment of patients with refractory ITP after splenectomy can be quite 
challenging. In cases of accessory spleen, surgical removal of the splenic tissue maybe 
necessary for treatment of thrombocytopenia. Anatomical imaging cannot easily distinguish 
splenic tissue from other abdominal lesions. In our case, 99mTc-DRBC scan was the most 
sensitive and specific imaging modality for identification and localization of accessory spleen. It 
showed more abnormal sites of splenic tissues than either US, CT scan or 99mTc-phytate scan. 
We suggest that 99mTc-DRBC scan be performed for assessment of the presence and location of 
the accessory splenic tissues which can substantially change the patient management. 
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Clinical case: gastroesophageal reflux scintigraphy in adult man with technical changes 
Ana Correia1; Denise Calado2; Nadine Silva2; Ana Alvernaz2; Eva Sousa1 
1 Lisbon School of Health Technology, Polytechnic Institute of Lisbon  
2Departamento de Medicina Molecular – Hospital da Luz 
 
Introduction: The clinical case described is a gastroesophageal reflux scintigraphy, a method 
for the detection and evaluation of gastroesophageal reflux (GER). This exam presents changes 
from that described in the literature. We used a different radiopharmaceutical (RF), ingested 
food, acidic solution, projections, position and time of image acquisition. These changes were 
applied because we didn’t have the recommended things to perform the exam. We want to 
prove the viability of the applied techniques. 
Methodology: We did the exam in adult man with 15.54 MBq of 99mTc-nanocolloid albumin 
mixed in orange and lemon juice and water (total of 300ml) that are administered per os. After 
that, the man drank a coffee (15ml) and water (50ml). We perform a dynamic study in 
orthostatic position (30s/frame) and static images in orthostatic position, supine position, 
prone position and knee-chest position. Were made maneuvers to induce reflux like valsalva 
maneuver and manual increased abdominal pressure. At 2 hours after RF administration and 
after ingestion of solid food with chocolate we perform a static image in supine position. All 
images were acquired with a low energy high resolution collimator and 128x128 matrix. 
Results: During the image acquisition we didn’t observe abnormal RF uptake suggestive of 
GER, except in the last acquired image after ingestion of a solid food with chocolate.   
Conclusions: The ingestion of solid food with chocolate was responsible for the detection of 
GER that means only the presence of reflux after ingestion of solid food. With the results of 
this exam we proved the viability of the applied techniques to detect GRE that can be 
implemented especially in cooperating individuals. 
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Introduction: 99mTc-HMPAO is a molecule with an unstable chemical structure, so it is essential 
to submit it to strict measures of quality control (QC). Innumerable procedures of QC have 
been studied, in order to present alternatives to obtain good results. The objective of the 
present study is to compare 4 methods of QC to determine the percentage of radiochemical 
purity (%RQP) of 99mTc-HMPAO. 
Methodology: The RQP was analysed through solvent extraction (SE), paper chromatography 
(PC), solid phase extraction (SPE) and thin layer chromatography (TLC) of 20 kits of Ceretec® 
stabilized and then measured at 0; 1.5; 2.5; 3.5 and 4.5 hours. The analysis was done through 
the comparison of the reference method (SE) with the other methods. 
Results and Discussion: There was a decrease of %RQP during the interval of time in which the 
study was carried out due to an instability in vitro of 99mTc-HMPAO. However, TLC method 
never presented an average of %RQP higher to 80% due to an undesirable migration of 
99mTcO4
- and 99mTc-HMPAO. PC was the most accurate method at 0h, but the time was 
00:14:10. SPE method presented the most higher mean values, however it overestimates the 
%RQP. The SE method presented a good reproducibility, 92.5±3.3% at 0h, and it’s practical, 
faster and cheaper. 
Conclusion: There are other methods that can be good alternatives for the QC described in the 
insert package of Ceretec®. Taking into consideration factors such as time, accuracy and 
economy, it is suggested the use of SE method as a routine QC. 
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Development of peptides for alpha-synuclein imaging 
Letícia Alves do Quental1; Paula Raposinho1; António Paulo1; Isabel Santos1 
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Progressive neurodegenerative disorders, such as Alzheimer´s (AD) and Parkinson´s (PD) 
diseases, affect millions of persons worldwide and pose a significant impact in public health, 
especially as more people approach old age. An essential process for the development of these 
diseases is the misfolding of proteins like A-beta, tau and alpha-synuclein (aSyn) and 
subsequent aggregation (amyloid deposits).  In PD, Dementia with Lewy bodies (DLB) and 
other synucleinopathies, aSyn was identified as the main component of Lewy bodies and Lewy 
neuritis, being considered a key pathological hallmark of these diseases. Therefore, 
compounds that target aSyn fibrils in vivo can be explored to design imaging agents for 
diagnosis and prognosis of PD. Herein, we describe the design, synthesis, characterization and 
pre-clinical evaluation of a number of peptides targeting aSyn fibrils. The peptides have been 
synthesized by solid-phase peptide synthesis (SPPS) and characterized by ESI-MS. The 
synthesized peptides were conjugated to fluorescein and to a prosthetic group in order to be 
visualized by optical imaging and to be labeled with 19F/18F, respectively. Moreover, the 
peptides contain a glucose unit to facilitate the crossing to the brain through the GLUT1 
transporter. The metabolic stability of these peptides has been assessed in mice´s liver and 
kidney homogenates and they have shown to be fairly stable. The evaluation of the binding of 
the several peptides to aSyn fibrils is underway. In this way, we expect to identify a selective 
aSyn-targeting peptide with biological features suitable for in vivo application. 
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Impact of residual catheter 18F-FDG activity on determination of SUV 
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Introduction (aim): The standardized uptake values (SUVs) are widely used in PET/CT for 
measuring the uptake of 18F-FDG in various tumors and it is of main importance in assessing 
the patient response to therapy. There are several factors that can introduce variation in the 
measurements of 18F-FDG uptake in tumors. Sometimes after the acquisition the residual 
activity in catheter visually seems significant. The aim of this study is to recognize if the 
residual activity of 18F-FDG introduces a significant variation in SUV value. 
Methodology: This study included 276 tumor lesions, primaries and metastases, from patients 
who performed PET/CT with 18F-FDG. The PET/CT acquisition was started about 1hour after the 
injection of 314.77 ± 47.14 MBq (mean ± SD). Patients with blood glycemia higher than 
140mg/dL were excluded. The SUVmax was determined with and without the residual activity of 
the catheter, both according to maximum pixel (threshold of 42%). 
Results: The mean value of SUV determined including the activity of the catheter (CAT+) was 
7.13 ± 5.01 (mean ± SD) and did not differ highly from SUV determined when the activity of the 
catheter was subtracted (CAT-), 7.35 ± 5.19 (mean ± SD). The mean residual activity measured 
in the catheter was 7.64 ± 6.11 (mean ± SD). From the application of the non-parametric test 
Wilcoxon to compare if the SUV CAT- is higher than the SUV CAT+, as the p (0.00) < α (0.05). 
We also verified that the SUV CT+ is significantly higher. The SUV values range variation 
between CAT+ and CAT- was between 0.0 and 4.5, with 0.21 ± 0.4 (mean ± SD). 
Discussion / Conclusions: Even considering that the residual activity of 18F-FDG did not 
introduce a significant variation in SUV value it is important to measure it mainly in small 
lesions and when the SUV is low, because they can easily introduce an error in comparative 
studies, used to evaluate therapy response. 
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Performance measurements of parallel hole collimators of a Philips Brightview gamma 
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Introduction: Collimators are one of the main gamma camera components affecting image 
quality. Lower quality or damaged collimators may affect certain performance parameters. In 
this way, a robust periodical QA protocol is of utmost importance in order to assure optimal 
clinical image quality. Thus, the main goal of this work was to assess the performance 
parameters of the parallel hole collimators of a Philips Brightview camera. Additionally, an 
optimized protocol for collimator performance assessment was suggested. 
Methods: The study involved the measurement of the following collimator parameters, 
according to IAEA and manufacturer’s specifications: integral uniformity, septal angulation, 
spatial resolution, sensitivity, and centre of rotation (COR). The proposed protocol suggests a 
collimator integrity screening in terms of uniformity and septal angulation assessment, 
followed by spatial resolution and sensitivity evaluation, only if needed. COR is always 
performed. The set of available collimators was tested: low energy high resolution (LEHR), 
medium energy general purposes (MEGP) and high energy general purposes (HEGP). 
Results: Integral uniformity for each pair of collimators was LEHR1: 9.48%, LEHR2: 9.46%, 
MEGP1: 9.37%, MEGP2: 9.40%, HEGP1: 9.41%, HEGP2: 9.92%. The septal angulation test 
showed slight misalignments for LEHR collimators. Mean spatial resolution was 3.84mm and 
3.91mm (LEHR2). Sensitivity tests showed similar values for both collimators, rounding 0.008%. 
COR errors were safely below the specifications. 
Conclusion: The obtained values showed a fair agreement with the manufacturer’s 
specifications, although the septal angulation test evidenced slight collimator hole 
misalignments in LEHR collimators, suggesting a foil fabrication method, which is more prone 
to defects. Additionally, the proposed optimized protocol seems to be more efficient, allowing 
to save time and avoid unnecessary collimator QA testing. 
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Patient Satisfaction in Nuclear Medicine Department of Royal Sussex County Hospital 
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Introduction: Assessment of patient satisfaction levels is a main item in evaluation of the 
quality of provided care. It intends to demonstrate if the care that is being provided suits 
patient’s expectations and it allows public recognition of good practices. Aim: To evaluate 
satisfaction of attended patients in Nuclear Medicine Department of Royal Sussex County 
Hospital (RSCH). 
Methodology: Retrospective study done in October 2011, with non-probabilistic sampling, 
based on the analysis of surveys filled by patients attended in Nuclear Medicine department of 
RSCH. For each answer option, a score and a classification were given: 0, 5, 10, being 10 the 
best feedback and 0 the worst one. Statistical analysis was done with the help of Excel 
(Microsoft®). Some of the evaluation factors were: staff dedication, ethics of healthcare 
professionals, privacy provided, communication performance, quality of given explanations, 
information transmission, patients’ comfort and opportunity to express themselves, conflict of 
information, improvements needed to be made. 
Results: Average scores ranged from 7.7 to 10. There was no question scored below 5.0. Mean 
score for the survey was 9.4±0.7. 
Conclusion: Overall results indicated high degree of satisfaction shown by the patients, with 
the only exception for the waiting times which showed the highest percentage of the lowest 
score. 
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Contribution of SPECT-IBZM in the differential diagnostic of Parkinson Syndromes 
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Introduction: The Parkinsonian syndromes reach worldwide 1-2 persons per 1,000 people, 
which reflect in the research of new methods of diagnostic. The brain Single Photon Emission 
Computed Tomography (SPECT), with the use of 123I-IBZM, has been promoted as important in 
the differential diagnosis of Parkinsonian syndromes (Parkinson’s disease, Progressive 
Supranuclear Palsy (PSP), Multisystemic Atrophy (MSA) and Essential Tremor). The IBZM 
demonstrates affinity for D2 receptors located postsynaptically, which compared with 
DaTSCAN that demonstrates fixation on presynaptic receptors, gives additional clinical 
information to complement the primary evaluation of the neurologist, confirming the 
existence of PSP, MSA, or Essential Tremor. 
Methodology: Literature search was undertaken through the portal b-on and in scientific 
journals, where the search words SPECT, IBZM, Parkinson Syndrome, Lewy Dementia and 
DaTSCAN were used to select several studies, which were subsequently revised. 
Results: The combination of DaTSCAN and IBZM allows differentiating and confirming, with 
94% sensitivity and 94% specificity, the existence of Parkinson's disease, PSP/MSA, and 
Essential Tremor. However, studies have shown that the use of IBZM-SPECT in conjunction 
with the study of cardiac innervation with MIBG allows for a differential diagnosis of 
Parkinsonian syndromes, with the benefit of reducing radiation exposure and exam cost. 
Conclusions: Given that DaTSCAN only identifies the presence of Parkinsonian syndromes in 
the patient, the combination with the IBZM study allows distinguishing between Parkinson’s 
disease and PSP/MSA with a great sensitivity and specificity. By these factors the IBZM-SPECT 
shows to be important in the differential diagnosis of Parkinsonian syndromes.  
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Multimodal Nuclear Imaging in Alzheimer´s Disease 
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Introduction: Alzheimer Disease (AD) is a progressive neurodegenerative disease associate to a 
neuronal function disruption and to a gradual cognition, function and individual behaviour 
deterioration. For his early diagnose, Nuclear Medicine (NM) offers functional methods such as 
Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography 
(PET), that combined with morphologic studies like Computed Tomography and Magnetic 
Resonance Imaging , provide cerebral perfusion and metabolism information, attenuation 
correction and anatomic mapping, that increase its sensibility and specificity. Brain SPECT 
using radiopharmaceuticals as 99mTc-HMPAO, 99mTc-ECD, 123I-IMP and 133Xe-SPECT, enables the 
therapeutics planning, patients follow-up and the estimation of Regional Cerebral Blood Flow 
that is helpful in AD diagnosis. On the other hand, PET scan features a vast amount of 
radiopharmaceuticals where 18F-FDG and 11C-PIB are the major examples. The first is clinical 
indicate for the glucose mechanism absolute quantification (decreased in AD patients) and the 
second is specific for βA plaques (degenerate in AD patients). 
Methodology: Data were obtained through bibliographic research, considering the PubMed®, 
international organizations and societies (WHO, SNM, EANM, Alzheimer’s Association, 
European Association for Brain Perfusion SPET), scientific journals (The Journal of Nuclear 
Medicine, International Journal of Alzheimer’s Disease), and standard guidelines. Key words: 
Alzheimer’s disease; SPECT; PET; dual-modality. 
Results: Considering the investigation typology it wasn´t obtain overall results. 
Discussion/Conclusion: NM exercises an important role on complementary diagnose for 
providing functional techniques, that early detect perfusion and metabolic changes, before the 
expression of structural changes. The fusion methods extensive development enables a more 
complete and exact knowledge about AD, with advantages for the patient. 
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Introduction: In Nuclear Medicine, the use of choline radiolabelled analogues as positrons 
emitters, like 11C and 18F, becomes a useful tool in malignancies detection and localization 
through Positron Emission Tomography (PET) and PET/Computed Tomography (CT). There are 
a vast amount of clinical applications namely for oncologic findings. The major application is on 
prostate cancer being referenced for the primary prostate cancer early detection, tumoral 
staging, presence of lymphatic involvement and tumoral recurrence. In cerebral cancer has 
been successful applied in cerebral lesions characterization and seems, when combined with 
Magnetic Resonance Imaging (MRI) to be a precise tool on high-risk gliomas and meningioma 
detection. Image with 11C on pulmonary cancer is used on malignant lesions and residual 
tumors detection. In the universe of digestive tract cancers stands out the esophagus and 
hepatocellular cancer. In bladder cancer emerges like a promising tool for the bladder 
transactional cell carcinoma pre-operative staging and contribute positively for the 
therapeutics selection distinguish patients who benefits of neo-adjuvant treatment from 
radical surgery. 
Methodology: Data were obtained through bibliographic research, considering the PubMed®, 
international and scientific organizations (Society for Experimental Biology and Medicine, 
EANM, Society of Nuclear Medicine and Molecular Imaging, American Cancer Society), 
scientific newspapers (The journal of Nuclear Medicine, The Journal of Urology), as well 
standard guidelines. Key-words: choline; radiopharmaceuticals; oncology; PET; PET/CT. 
Results: Considering the investigation typology it wasn´t obtain overall results. 
Discussion/Conclusion: Prostate, cerebral, such as meningioma and gliomas, pulmonary, 
digestive tract, on liver and esophagus, and bladder cancer are presented as the major areas of 
interest to approach with greater benefits providing a high sensibility in these pathologies 
detection. 
  
 23 I International Conference of Nuclear Medicine Technologies 
 
 
PP – 13 
10h00-10h30, Saturday, May 31, 2014 
 
Renal Function in Renogram: Comparison of Two Algorithms for Image Processing 
Ana Silva1; Maria Cristina Amorim1; Ana Sofia Lamarosa2; Elísio Sousa2; Elisabete Carolino3; Maria João Carapinha3 
1 Nuclear Medicine Technologist 
2 Department of Nuclear Medicine UIC - Hospital Particular do Algarve 
3 Lisbon School of Health Technology, Polytechnic Institute of Lisbon 
 
Introduction: The renogram (RNG) enables the evaluation of morphology and function of the 
urinary system. 99mTc-MAG3 is the most widely used radiopharmaceutical for studies in 
pediatric settings. For calculation of the parameters of renal function (RF) some processing 
algorithms are used. We studied the MAG3 Without Samples (MWS) and QuantEM Expert 
(QEE), the most applied in Portugal in nuclear medicine. Aim: evaluate the correlation of RF in 
RNG, with the processing algorithms MWS and QEE. 
Methods: Retrospective study, with non-probalilistic sampling by convenience of 21 pediatric 
patients with clinical indication to 99mTc-MAG3 diuretic RNG with furosemide. Protocols were 
made in agreement with the standards of the department where the data were collected. The 
following variables were calculated: depth, time to peak, differential RF and time to ½ Lasix®, 
of the right and left kidney; effective renal plasma flow (ERPF); MAG3 clearance (body surface 
area and weight, normalized). For calculation of the MAG3 clearance, QEE had different 
weightings (pediatric (QEE-p) and adults (QEE-a)) and MWS applied the same coefficients in 
the two studies. Descriptive and inferential statistical analysis (Shapiro-Wilk test, T-test and 
Wilcoxon test), with α=0.05. The ethical and confidentiality principles were considered.  
Results: The depth, time to peak, differential RF and time to ½ Lasix®, of the right and left 
kidney, and ERPF, didn’t show statistically significant differences (p>0.05). The average MAG3 
clearance given by MWS is lower than by QEE-a, with exception of MWS/total-QEE-a, which 
didn’t show statistically significant difference (p>0.05). The average MAG3 clearance in total-
MWS/total-QEE-p and total-MWS/QEE-p, show statistically significant difference (p≤0.05). 
Conclusion: MWS and QEE provide the same outputs but with variation on standardization 
parameters. It’s important that the operator understand the algorithm used in order to obtain 
standardization of results. 
